SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing an intense rally driven by a structural memory supercycle, where extreme demand for AI-optimized HBM and DRAM has created a persistent supply bottleneck expected to last through 2027. Community sentiment is overwhelmingly bullish, with investors aggressively debating the potential for a stock split and further valuation rerating as the company transitions from a cyclical memory maker to critical AI infrastructure.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors focus on the company's progress with mRNA-based pipeline developments, including an investigational cancer therapy and a combination vaccine for flu and COVID-19. The stock is seeing heightened activity fueled by positive institutional sentiment and active discussions regarding potential breakthroughs in its oncology platform.

Sun Communities, Inc. provides real estate management services. The firm operates through the following segments: Manufactured Home Communities, Recreational Vehicle, and Marina. The Manufactured Home Communities segment owns, operates, and develops manufactured housing communities and is in the business of acquiring, operating, and developing ground up communities to provide housing solutions. The Recreational Vehicle segment focuses on the development of recreational vehicle resorts and is in the business of acquiring, operating and developing ground up resorts throughout the U.S. and in Ontario, Canada. The Marina segment operates marinas and is in the business of acquiring and operating marinas throughout the U.S. The company was founded in 1975 and is headquartered in Southfield, MI.

Sun Communities, Inc.

Sun Communities, Inc. (SUI) is trending due to significant attention on its recent financial performance, including core FFO results and dividend announcements. While the ticker shares a symbol with a popular digital asset, community discussion is split between analysis of this REIT's operations and confusion with the crypto token activity.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing explosive momentum driven by speculative optimism surrounding a preliminary foundry agreement with Apple and broader enthusiasm for its expanding role as a domestic U.S. chip manufacturer. Community discussions are dominated by hyper-bullish sentiment and debate over whether this vertical price action represents a sustainable structural repricing or an overextended bubble driven by FOMO.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing increased market volatility and momentum as investors react to the company's Q1 revenue growth, an expanded pipeline of Matrix-M licensing agreements, and heightened chatter regarding its potential involvement in addressing the Hantavirus outbreak. The community is actively debating the company's ability to transition from a single-product pandemic name into a sustainable biotechnology partner, with significant focus on the potential for new high-value oncology or infectious disease collaborations.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

Lynas Rare Earths is gaining significant attention as investors position the company as a primary beneficiary of Western supply chain diversification away from China. The community is actively discussing the strategic importance of Lynas' expansion into heavy rare earth separation in Malaysia and its U.S.-backed facility in Texas as essential developments for securing supply chains in the defense and electrification sectors.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting a positive pre-BLA meeting with the FDA, which confirmed the efficacy of its sonelokimab program for treating hidradenitis suppurativa and solidified its path toward a BLA submission. The community is actively discussing the stock's potential for a significant re-rating, with many focusing on upcoming 52-week clinical data readouts and speculating on a potential buyout given the drug's best-in-class label profile.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently trending as investors debate whether the sector is experiencing a sustainable AI-driven secular bull market or a late-stage parabolic bubble reminiscent of the dot-com era. Community sentiment is deeply divided between aggressive bulls who point to sustained AI infrastructure demand and skeptical bears who are hedging against potential volatility through leveraged inverse positions and long-dated put options.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is trending as investors aggressively speculate on its role in edge AI and specialized defense-grade storage, fueling a sharp momentum-driven move that has drawn comparisons to larger memory sector peers. Community sentiment is divided between those betting on a parabolic squeeze due to a low float and institutional interest, and those warning of overvaluation, pending legal challenges, and insider selling.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant investor interest as a primary proxy for pre-IPO exposure to high-profile companies like SpaceX and Anthropic. Community discussion is focused on the fund's potential Net Asset Value upside, the anticipation surrounding upcoming IPO timelines, and debate over its valuation premium compared to broader market alternatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These Catalysts are Triggering Massive Momentum

From enterprise AI clouds to breakthrough biotech catalysts, several emerging and mid-cap companies are capturing investor attention as transformative technologies accelerate commercialization and strategic partnerships deepen across industries. $XERI, $RXT, $NTHI, $GLE, $SOBR, $FLNC

Biotech’s Next Wave May Already be in Motion

The biotech and pharma sector is entering one of its most pivotal periods in years, where insider conviction, late-stage clinical wins, and platform technologies are converging to reshape both valuations and patient outcomes. From aggressive insider buying ahead of critical data to blockbuster Phase 3 readouts redefining entire therapeutic categories, the market is signaling that the next cycle of winners may already be taking shape. $NTHI, $ERNA, $LLY, $NVO, $REGN, $MRNA

Where Executives Are Doubling Down on Their Companies’ Fortunes

As market participants are sifting through data, one signal often cuts through the noise: insiders putting real money to work. Executives and strategic stakeholders have been accumulating shares in meaningful size, ranging from six-figure buys to billion-dollar commitments. While insider buying is never a guarantee of upside, it frequently reflects conviction rooted in operational visibility, upcoming catalysts, or perceived undervaluation. $NTHI, $RIVN, $SRAD, $NWBI, $FGBI

Insider Signals and Potential Moonshots that Could Reset Valuations

Biotech and pharma markets are leading the way in a sharply selective environment at midday, where clinical data, insider conviction, and platform scalability are driving outsized moves while weaker narratives get left behind. $NTHI, $POET, $SDOT, $BDRX, $CLRB, $DOCN, $FSLY, $EWTX, $BLDP

Markets On Fire: Biotech Breakthroughs and AI Mega-Deals Move Wall Street

$CLRB, $NTHI, $BLZE, $DGXX, $VRDN, $CYTK are among today's leading stocks

NeOnc CEO Doubles Down with Insider Conviction Ahead of Critical Brain Cancer Data

NeOnc Technologies (NASDAQ:NTHI) is entering a high-stakes stretch and its CEO is making sure the market notices. In a series of open-market transactions, CEO and Executive Chairman Amir Heshmatpour has committed over $500,000 in recent weeks, bringing his total personal investment in the company to nearly $1 million over the past year. The timing is not subtle: it comes just as NeOnc approaches key clinical data readouts that could define its trajectory in the competitive field of brain cancer therapeutics.

NeOnc President Adds Shares

A fresh insider signal just hit the tape for NeOnc Technologies Holdings (NASDAQ:NTHI), and it’s the kind of move traders tend to notice.

Neonc Technologies (NASDAQ:NTHI) President Amir Heshmatpour Buys 10,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour acquired 10,000 shares of the business's stock in a transaction on Thursday, April 23rd. The shares were...

Amir Heshmatpour Acquires 10,000 Shares of Neonc Technologies (NASDAQ:NTHI) Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour acquired 10,000 shares of the firm's stock in a transaction dated Friday, April 10th. The shares were...

Neonc Technologies (NASDAQ:NTHI) President Purchases $25,950.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour purchased 5,000 shares of the company's stock in a transaction on Thursday, April 9th. The shares were purchased at an average cost of $5.19 per share, with a total value of $25,950.00. Following the...

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

NeOnc Technologies Holdings Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$5.45
Prev Close	$6.49
Open	$6.50
Dividend Yield	0.00%
50-Day Moving Average	$6.70
Beta	0.00
Avg. Volume	66,435.06
PE Ratio	-1.53

52-Week High	$12.99
52-Week Low	$3.20
Market Capitalization	$137.81M
EPS (Annual)	-$2.87
Price to Book	-6.75
Revenue Per Employee	$7,998.00

NTHI
NeOnc Technologies Holdings Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NTHI News

NTHINeOnc Technologies Holdings Inc.